ARCHIVES

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

This article is from The Cancer Letter archive.

Vol. 08 No. 31 | July 30, 1982

Download PDF Visit The Full Archive

Related Articles

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001